
SelectQuote (SLQT) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our Fast-Paced Momentum at a Bargain screen.
SelectQuote (SLQT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
SelectQuote surges 17% on strong earnings beat
Image source: The Motley Fool.DATEWednesday, February 25, 2026 at 9:30 a.m. ETCALL PARTICIPANTSCo-Chief Executive Officer — Brad MarshallCo-Chief Executive Officer — Jonathan BockChief Financial Officer — Teddy DeslogePresident — Carlos WhitakerManaging Director, Investor Relations — Stacy WangNeed a quote from a Motley Fool analyst? Email [email protected] Investment Income (NII) -- $0.80 per share, representing an 11.8% annualized return on equity; NII covered the quarterly dividend...
NEW YORK, Sept. 28, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of SelectQuote, Inc. (NYSE: SLQT) between September 9, 2020 and May 1, 2025, both dates inclusive (the “Class Period”), of the important October 10, 2025 lead plaintiff deadline.
SLQT Investors with Losses Encouraged to Contact Hagens Berman SLQT Investors with Losses Encouraged to Contact Hagens Berman
NEW YORK, Sept. 21, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of SelectQuote, Inc. (NYSE: SLQT) between September 9, 2020 and May 1, 2025, both dates inclusive (the “Class Period”), of the important October 10, 2025 lead plaintiff deadline.
NEW YORK, June 29, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of SelectQuote, Inc. (NYSE: SLQT) resulting from allegations that SelectQuote may have issued materially misleading business information to the investing public.
NEW YORK, June 22, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of SelectQuote, Inc. (NYSE: SLQT) resulting from allegations that SelectQuote may have issued materially misleading business information to the investing public.
NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of SelectQuote, Inc. (NYSE: SLQT) resulting from allegations that SelectQuote may have issued materially misleading business information to the investing public.
NEW YORK, May 24, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of SelectQuote, Inc. (NYSE: SLQT) resulting from allegations that SelectQuote may have issued materially misleading business information to the investing public.
Veteran health insurance broker SelectQuote (NYSE: SLQT) wasnt quite looking like the wave of the future on Monday. The companys shares took a 12% hit on the day, following managements release of the latest set of quarterly figures. That was in rather sharp contrast to the overall stock market, where the benchmark S&P 500 index rose by a relatively steep 3.3%. Healthy growth, but a bottom-line miss For its fiscal third quarter of 2025, SelectQuote reaped just over $408 million in total revenu...
SAN FRANCISCO, May 07, 2025 (GLOBE NEWSWIRE) -- On May 1, 2025, investors in SelectQuote (NYSE: SLQT) saw the price of their shares tumble over 19% after the U.S. Department of Justice announced it had filed a lawsuit against the company, other insurance brokers, and three of the nation’s largest health insurance companies, claiming violations of the False Claims Act.
NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against SelectQuote, Inc. (“SelectQuote” or the “Company”) (NYSE: SLQT) on behalf of SelectQuote stockholders. Our investigation concerns whether SelectQuote has violated the federal securities laws and/or engaged in other unlawful business practices.
The average of price targets set by Wall Street analysts indicates a potential upside of 33.5% in SelectQuote (SLQT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
SLQT earnings call for the period ending December 31, 2024.
SelectQuote (SLQT) delivered earnings and revenue surprises of 233.33% and 14.27%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
After-hours movers: Coty, SelectQuote, Harmonic, Lattice Semi and more
SelectQuote, Inc. (NYSE: SLQT) (the “Company”), a leading distributor of Medicare insurance policies and owner of a rapidly-growing healthcare service
SLQT earnings call for the period ending September 30, 2024.